Ongoing work to define the role of these pathways using in vivo systems will provide a better understanding on how modulating the tumor microenvironment affects the progression of HSA, as well as how these pathways might influence progression of human angiosarcoma. This evidence concerns the gene ALB and angiosarcoma.